Common Protocol: CJC-1295: 100200 mcg 12x daily, subcutaneous Ipamorelin: 100200 mcg 12x daily, subcutaneous (often injected together with CJC-1295) Cycle: 812 weeks, can be run longer depending on goals 4
Like, Why not
It transforms, neutralizes, and eliminates compounds through complex enzymatic mechanisms, while managing the metabolism of fats, sugars, proteins, and hormones
It functions as a highly specific inhibitor of an enzyme called NNMT (Nicotinamide N-methyltransferase)
Nature of Adverse Events The most commonly reported fatal complications include: Acute pancreatitis : Sudden inflammation of the pancreas, often requiring hospitalization and linked to severe abdominal pain, nausea, and fever Organ failure : In some cases, GLP-1RA drugs have been suspected of contributing to multi-organ dysfunction Cardiovascular events : Though rare, some deaths have involved cardiac arrest or stroke following GLP-1RA use Complications from off-label or unsupervised use : Several cases involved individuals obtaining GLP-1RA drugs from unregulated online sources or using counterfeit pens Its important to note that these reports do not confirm causality
